VABYSMO
VABYSMO
Approved
DIN Number
02527618
Drug Class
Human
Market Date
Jul 18, 2022
Company
HC
Hoffmann-La Roche Limited
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02527618
AIG Number0163722001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
S01LA09 FARICIMAB
Product Specifications
Dosage FormSolution
Route of AdministrationIntravitreal
AHFS Classification52:92.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
FARICIMABActive
Strength: 6 MG / 0.05 ML
Monograph: FARICIMAB